We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

2e3o

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2e3o.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:2e3o.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2e3o| PDB=2e3o | SCENE= }}
{{STRUCTURE_2e3o| PDB=2e3o | SCENE= }}
-
'''Crystal structure of CERT START domain in complex with C16-ceramide (P212121)'''
+
===Crystal structure of CERT START domain in complex with C16-ceramide (P212121)===
-
==Overview==
+
<!--
-
In mammalian cells, ceramide is synthesized in the endoplasmic reticulum and transferred to the Golgi apparatus for conversion to sphingomyelin. Ceramide transport occurs in a nonvesicular manner and is mediated by CERT, a cytosolic 68-kDa protein with a C-terminal steroidogenic acute regulatory protein-related lipid transfer (START) domain. The CERT START domain efficiently transfers natural D-erythro-C16-ceramide, but not lipids with longer (C20) amide-acyl chains. The molecular mechanisms of ceramide specificity, both stereo-specific recognition and length limit, are not well understood. Here we report the crystal structures of the CERT START domain in its apo-form and in complex with ceramides having different acyl chain lengths. In these complex structures, one ceramide molecule is buried in a long amphiphilic cavity. At the far end of the cavity, the amide and hydroxyl groups of ceramide form a hydrogen bond network with specific amino acid residues that play key roles in stereo-specific ceramide recognition. At the head of the ceramide molecule, there is no extra space to accommodate additional bulky groups. The two aliphatic chains of ceramide are surrounded by the hydrophobic wall of the cavity, whose size and shape dictate the length limit for cognate ceramides. Furthermore, local high-crystallographic B-factors suggest that the alpha-3 and the Omega1 loop might work as a gate to incorporate the ceramide into the cavity. Thus, the structures demonstrate the structural basis for the mechanism by which CERT can distinguish ceramide from other lipid types yet still recognize multiple species of ceramides.
+
The line below this paragraph, {{ABSTRACT_PUBMED_18184806}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 18184806 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_18184806}}
==About this Structure==
==About this Structure==
Line 32: Line 36:
[[Category: Lipid transfer protein]]
[[Category: Lipid transfer protein]]
[[Category: Lipid transport]]
[[Category: Lipid transport]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 01:51:51 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 02:58:44 2008''

Revision as of 23:58, 28 July 2008

Image:2e3o.png

Template:STRUCTURE 2e3o

Crystal structure of CERT START domain in complex with C16-ceramide (P212121)

Template:ABSTRACT PUBMED 18184806

About this Structure

2E3O is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide., Kudo N, Kumagai K, Tomishige N, Yamaji T, Wakatsuki S, Nishijima M, Hanada K, Kato R, Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):488-93. Epub 2008 Jan 9. PMID:18184806

Page seeded by OCA on Tue Jul 29 02:58:44 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2e3o"
Personal tools